Phibro Animal Health price target raised to $21 from $20 at Morgan Stanley

Morgan Stanley raised the firm’s price target on Phibro Animal Health (PAHC) to $21 from $20 and keeps an Equal Weight rating on the shares. The “broad-based beat” in fiscal Q3 and guidance raise “should lift the shares,” the analyst tells investors in a post-earnings note.